AzTrials
AzTrials

Dentinal HypersensitivityNCT03553290

Therapeutic Evaluation of Lower-level Laser for Treating Dentinal Hypersensitivity

A study testing A.R.C. FOX Laser-FOX Q-810nm in people with Dentinal Hypersensitivity, run by National Taiwan University Hospital at 1 site in Taiwan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this study was to evaluate the efficacy of low energy laser for the treatment of dentinal hypersensitivity due to periodontal therapy. Read more about this study

Who is it for?
Ages 20 to 80 years
Conditions the study is for
Dentinal Hypersensitivity
What is being tested?
A.R.C. FOX Laser-FOX Q-810nm
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
80 participants
Where
1 siteTaiwan
Study dates
10 Aug 2017to 31 Aug 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 1.20-80 year-old with their own will and oral cleaning ability 2.Patients who have been diagnosed with periodontitis and have completed periodontal treatment 3.Gingival recession in at least two regions showed sensitivity of teeth (VAS> 5) 4.No systemic infection 5.No painkillers in the past two weeks 6.Not pregnant or lactating

Who cannot join

  • 1.Smoking more than half a pack a day in the past month

Trial locations and contacts

1 site in 1 country.

Taiwan1 site, 1 recruiting
  • National Taiwan University Hospital

    Taipei

    Po-Chun Chang, 02-23123456 ext. 67709, changpc@ntu.edu.tw

    Recruiting

Other trials in Taiwan

About this study

Official title: Lower-level Laser for Treating Dentinal Hypersensitivity

The aim of this study was to evaluate the efficacy of low energy laser for the treatment of dentinal hypersensitivity due to periodontal therapy.

Read the detailed description

We will recruit 80 adult patients with obvious symptom of hypersensitivity after periodontal therapy. They will receive low-energy laser treatment, and the area without the symptom of hypersensitivity will be served as control. Changes in pain status and clinical periodontal index within six months of treatment will be recorded.

Being tested
A.R.C. FOX Laser-FOX Q-810nm, Control
Keywords
Dentistry, Dentinal Hypersensitivity, lower-level laser therapy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • A.R.C. FOX Laser-FOX Q-810nmDevice

    805-810 nm dichotomous laser, 12 Watt within the power of sensitive parts of the affected teeth

  • ControlProcedure or surgery

    Mechanical debridement alone

Study groups in NCT03553290
Study groupRoleWhat they receive
controlSham comparatorMechanical debridement alone
Receives: Procedure: Control
lower-level laser TherapyActive comparatorMechanical debridement with lower-level laser therapy Device: A.R.C. FOX Laser-FOX Q-810nm Mechanical debridement with lower-level laser therapy
Receives: Device: A.R.C. FOX Laser-FOX Q-810nm

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in mental status

    Visual analogue scale analysis with a score range of 0-10 (0: no discomfort; 10: severe discomfort). Lower score represent a better outcome.

    Measured: 6 months

Secondary outcomes (4)
  1. Change in probing depth

    Measure at six surfaces of tooth

    Measured: 6 months

  2. Change in clinical attachment level

    Measure at six surfaces of tooth

    Measured: 6 months

  3. Change in gingival recession

    Measure at six surfaces of tooth

    Measured: 6 months

  4. Change in masticatory mucosa

    Measure at mid-buccal aspect of tooth

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jun 2018
  2. Study start10 Aug 2017
  3. Primary completion31 Aug 2018 (estimated)
  4. Study completion31 Aug 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Single group
Model description
Split-mouth design in the same individual
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03553290
Sponsor's protocol ID
201701057DIPA
Status last verified
Mar 2018
First submitted
15 Aug 2017
Last updated
18 Jun 2018
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing A.R.C. FOX Laser-FOX Q-810nm in people with Dentinal Hypersensitivity, run by National Taiwan University Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Jun 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Po-Chun Chang (02-23123456 ext. 67709, changpc@ntu.edu.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in mental status (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jun 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in